![]()
|
|
||||||||
J. Biol. Chem., Vol. 266, Issue 4, 2647-2651, Feb, 1991
RM Crowl, TJ Stoller, RR Conroy and CR Stoner
Serum levels of phospholipase A2 (PLA2) activity have been shown to be
elevated in cases of septic shock and rheumatoid arthritis. The cellular
origin of serum PLA2, however, is not known. In this report, we demonstrate
that human group II PLA2 expression and secretion are induced in hepatoma
cells (HepG2) following treatment with interleukin- 6 (IL-6), tumor
necrosis factor (TNF), and interleukin-1 (IL-1). Of the three cytokines,
IL-6 is the most potent. Significant synergy is observed between IL-6 and
IL-1 and between IL-6 and TNF, but not between IL-1 and TNF. PLA2 induction
does not occur in human YT cells, which are known to have receptors for
both IL-1 and IL-6, indicating that the regulatory mechanism involved is
cell type-specific. The results of RNA blot analysis indicate that the PLA2
gene is regulated in HepG2 cells at the pretranslational level. Induction
of PLA2 synthesis in HepG2 cells in response to these cytokines resembles
the induction of the acute phase plasma proteins which are synthesized in
cultured hepatocytes and hepatoma cells following exposure to the same
cytokines and in liver in response to inflammation and infection. In
addition, a putative IL-6-responsive element, which is homologous to a
similar element found in several acute phase genes, is present in the
5'-promoter-proximal region of the PLA2 gene. These results suggest that
serum PLA2 is synthesized in and secreted from liver cells in response to
inflammatory stimuli, mediated primarily by IL-6, and therefore should be
classified as an acute phase protein.
Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response
Department of Molecular Genetics, Hoffmann-La Roche Inc., Nutley, New Jersey 07110.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. N. Birts, C. H. Barton, and D. C. Wilton A Catalytically Independent Physiological Function for Human Acute Phase Protein Group IIA Phospholipase A2: CELLULAR UPTAKE FACILITATES CELL DEBRIS REMOVAL J. Biol. Chem., February 22, 2008; 283(8): 5034 - 5045. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Han, B. Chen, and T. J. Smith Jak2 Dampens the Induction by IL-1beta of Prostaglandin Endoperoxide H Synthase 2 Expression in Human Orbital Fibroblasts: Evidence for Divergent Influence on the Prostaglandin E2 Biosynthetic Pathway J. Immunol., November 15, 2007; 179(10): 7147 - 7156. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kuwata, C. Fujimoto, E. Yoda, S. Shimbara, Y. Nakatani, S. Hara, M. Murakami, and I. Kudo A Novel Role of Group VIB Calcium-independent Phospholipase A2 (iPLA2{gamma}) in the Inducible Expression of Group IIA Secretory PLA2 in Rat Fibroblastic Cells J. Biol. Chem., July 13, 2007; 282(28): 20124 - 20132. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kontush and M. J. Chapman Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis Pharmacol. Rev., September 1, 2006; 58(3): 342 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kuwata, T. Nonaka, M. Murakami, and I. Kudo Search of Factors That Intermediate Cytokine-induced Group IIA Phospholipase A2 Expression through the Cytosolic Phospholipase A2- and 12/15-Lipoxygenase-dependent Pathway J. Biol. Chem., July 8, 2005; 280(27): 25830 - 25839. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Han, A. J. Demetris, G. Michalopoulos, J. H. Shelhamer, and T. Wu 85-kDa cPLA2 plays a critical role in PPAR-mediated gene transcription in human hepatoma cells Am J Physiol Gastrointest Liver Physiol, April 1, 2002; 282(4): G586 - G597. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Koduri, J. O. Gronroos, V. J. O. Laine, C. Le Calvez, G. Lambeau, T. J. Nevalainen, and M. H. Gelb Bactericidal Properties of Human and Murine Groups I, II, V, X, and XII Secreted Phospholipases A2 J. Biol. Chem., February 15, 2002; 277(8): 5849 - 5857. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nijmeijer, W. K Lagrand, A. Baidoshvili, Y. T.P Lubbers, W. T. Hermens, C. J.L.M Meijer, C. A Visser, C.E. Hack, and H. W.M Niessen Secretory type II phospholipase A2 binds to ischemic myocardium during myocardial infarction in humans Cardiovasc Res, January 1, 2002; 53(1): 138 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Balto, H. Sasaki, and P. Stashenko Interleukin-6 Deficiency Increases Inflammatory Bone Destruction Infect. Immun., February 1, 2001; 69(2): 744 - 750. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. COWAN, X. HUANG, X. L. YAO, and J. H. SHELHAMER Tumor Necrosis Factor Alpha Stimulation of Human Clara Cell Secretory Protein Production by Human Airway Epithelial Cells Ann. N.Y. Acad. Sci., December 1, 2000; 923(1): 193 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Nyman, P. Ojala, V. J.O. Laine, and T. J. Nevalainen Distribution of Group II Phospholipase A2 Protein and mRNA in Rat Tissues J. Histochem. Cytochem., November 1, 2000; 48(11): 1469 - 1478. [Abstract] [Full Text] |
||||
![]() |
H. Kern, W. Johnen, J. Braun, B. Frey, B. Rustow, W. J. Kox, and M. Schlame Heparin Induces Release of Phospholipase A2 into the Splanchnic Circulation Anesth. Analg., September 1, 2000; 91(3): 528 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Baek, T. K. Kwon, J.-H. Lim, Y.-J. Lee, H.-W. Chang, S.-J. Lee, J.-H. Kim, and K.-B. Kwun Secretory Phospholipase A2-Potentiated Inducible Nitric Oxide Synthase Expression by Macrophages Requires NF-{kappa}B Activation J. Immunol., June 15, 2000; 164(12): 6359 - 6365. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Triggiani, F. Granata, A. Oriente, V. De Marino, M. Gentile, C. Calabrese, C. Palumbo, and G. Marone Secretory Phospholipases A2 Induce {beta}-Glucuronidase Release and IL-6 Production from Human Lung Macrophages J. Immunol., May 1, 2000; 164(9): 4908 - 4915. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Kovanen and M. O. Pentikainen Secretory Group II Phospholipase A2 : A Newly Recognized Acute-Phase Reactant With a Role in Atherogenesis Circ. Res., March 31, 2000; 86(6): 610 - 612. [Full Text] [PDF] |
||||
![]() |
W. E. M. Schouten, M. P. C. Grooteman, A.-J. van Houte, M. Schoorl, J. van Limbeek, and M. J. Nube Effects of dialyser and dialysate on the acute phase reaction in clinical bicarbonate dialysis Nephrol. Dial. Transplant., March 1, 2000; 15(3): 379 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. J. O. Laine, D. S. Grass, and T. J. Nevalainen Resistance of Transgenic Mice Expressing Human Group II Phospholipase A2 to Escherichia coli Infection Infect. Immun., January 1, 2000; 68(1): 87 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Dorsam, M. M. Taher, K. C. Valerie, N. B. Kuemmerle, J. C. Chan, and R. C. Franson Diphenyleneiodium Chloride Blocks Inflammatory Cytokine-Induced Up-Regulation of Group IIA Phospholipase A2 in Rat Mesangial Cells J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 271 - 279. [Abstract] [Full Text] |
||||
![]() |
J. Ishizaki, N. Suzuki, K.-i. Higashino, Y. Yokota, T. Ono, K. Kawamoto, N. Fujii, H. Arita, and K. Hanasaki Cloning and Characterization of Novel Mouse and Human Secretory Phospholipase A2s J. Biol. Chem., August 27, 1999; 274(35): 24973 - 24979. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Lagrand, C. A. Visser, W. T. Hermens, H. W. M. Niessen, F. W. A. Verheugt, G.-J. Wolbink, and C. E. Hack C-Reactive Protein as a Cardiovascular Risk Factor : More Than an Epiphenomenon? Circulation, July 6, 1999; 100(1): 96 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. J. O. Laine, D. S. Grass, and T. J. Nevalainen Protection by Group II Phospholipase A2 Against Staphylococcus aureus J. Immunol., June 15, 1999; 162(12): 7402 - 7408. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Eickelberg, M. Roth, R. Mussmann, J. J. Rudiger, M. Tamm, A. P. Perruchoud, and L.-H. Block Calcium Channel Blockers Activate the Interleukin-6 Gene Via the Transcription Factors NF-IL6 and NF-{kappa}B in Primary Human Vascular Smooth Muscle Cells Circulation, May 4, 1999; 99(17): 2276 - 2282. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Knight, C. P. Lydell, D. Zhou, T. D. Weir, R. Robert Schellenberg, and T. R. Bai Leukemia Inhibitory Factor (LIF) and LIF Receptor in Human Lung . Distribution and Regulation of LIF Release Am. J. Respir. Cell Mol. Biol., April 1, 1999; 20(4): 834 - 841. [Abstract] [Full Text] |
||||
![]() |
D. Beasley COX-2 and cytosolic PLA2 mediate IL-1beta -induced cAMP production in human vascular smooth muscle cells Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1369 - H1378. [Abstract] [Full Text] [PDF] |
||||
![]() |
T BERTSCH, E G FISCHER, Y HORI, S FURUE, K KUWABARA, J IKEUCHI, K TANAKA, H ONOYAMA, and M YAMAMOTO Phospholipase A2 and acute pancreatitis in rats • Reply Gut, February 1, 1999; 44(2): 290 - 290. [Full Text] [PDF] |
||||
![]() |
X. L. Yao, S. J. Levine, M. J. Cowan, C. Logun, and J. H. Shelhamer Tumor Necrosis Factor-alpha Stimulates Human Clara Cell Secretory Protein Production by Human Airway Epithelial Cells Am. J. Respir. Cell Mol. Biol., October 1, 1998; 19(4): 629 - 635. [Abstract] [Full Text] |
||||
![]() |
F. Jin, C. F. Nathan, D. Radzioch, and A. Ding Lipopolysaccharide-Related Stimuli Induce Expression of the Secretory Leukocyte Protease Inhibitor, a Macrophage-Derived Lipopolysaccharide Inhibitor Infect. Immun., June 1, 1998; 66(6): 2447 - 2452. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Blom, A.T.J. Tool, P.C. Wever, G.J. Wolbink, M.C. Brouwer, J. Calafat, A. Egesten, E.F. Knol, C.E. Hack, D. Roos, et al. Human Eosinophils Express, Relative to Other Circulating Leukocytes, Large Amounts of Secretory 14-kD Phospholipase A2 Blood, April 15, 1998; 91(8): 3037 - 3043. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bruins, H. t. Velthuis, P. G. M. Jansen, L. Eijsman, and C. Erik Hack Biphasic release of secretory phospholipase A2 during and after cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., April 1, 1998; 115(4): 949 - 951. [Full Text] [PDF] |
||||
![]() |
L. Pantoni, C. Sarti, and D. Inzitari Cytokines and Cell Adhesion Molecules in Cerebral Ischemia : Experimental Bases and Therapeutic Perspectives Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 503 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Romano, E. Romano, S. Bjorkerud, and E. Hurt-Camejo Ultrastructural Localization of Secretory Type II Phospholipase A2 in Atherosclerotic and Nonatherosclerotic Regions of Human Arteries Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 519 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. LaPointe and J. R. Sitkins Phospholipase A2 Metabolites Regulate Inducible Nitric Oxide Synthase in Myocytes Hypertension, January 1, 1998; 31(1): 218 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Furue, Y Hori, K Kuwabara, J Ikeuchi, H Onoyama, M Yamamoto, and K Tanaka Increased activity of group II phospholipase A2 in plasma in rat sodium deoxycholate induced acute pancreatitis Gut, December 1, 1997; 41(6): 826 - 831. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Anderson, A. Roshak, J. D. Winkler, M. McCord, and L. A. Marshall Cytosolic 85-kDa Phospholipase A2-mediated Release of Arachidonic Acid Is Critical for Proliferation of Vascular Smooth Muscle Cells J. Biol. Chem., November 28, 1997; 272(48): 30504 - 30511. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Nevalainen, V. J. O. Laine, and D. S. Grass Expression of Human Group II Phospholipase A2 in Transgenic Mice J. Histochem. Cytochem., August 1, 1997; 45(8): 1109 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hurt-Camejo, S. Andersen, R. Standal, B. Rosengren, P. Sartipy, E. Stadberg, and B. Johansen Localization of Nonpancreatic Secretory Phospholipase A2 in Normal and Atherosclerotic Arteries: Activity of the Isolated Enzyme on Low-Density Lipoproteins Arterioscler. Thromb. Vasc. Biol., February 1, 1997; 17(2): 300 - 309. [Abstract] [Full Text] |
||||
![]() |
A. K. Roshak, E. A. Capper, C. Stevenson, C. Eichman, and L. A. Marshall Human Calcium-independent Phospholipase A2 Mediates Lymphocyte Proliferation J. Biol. Chem., November 10, 2000; 275(46): 35692 - 35698. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Peilot, B. Rosengren, G. Bondjers, and E. Hurt-Camejo Interferon-gamma Induces Secretory Group IIA Phospholipase A2 in Human Arterial Smooth Muscle Cells. INVOLVEMENT OF CELL DIFFERENTIATION, STAT-3 ACTIVATION, AND MODULATION BY OTHER CYTOKINES J. Biol. Chem., July 21, 2000; 275(30): 22895 - 22904. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |